Although it has been recently shown that application of EA elevates cytosolic Ca2+ concentration in tumor and non-tumor cells, the large component of the elevation was relatively resistant to conventional inhibitors of TRPC4 and TRPC5, ML204 and clemizole (Clm)9,10. The gene discussed is TRPC5; the disease is neoplasm.